2009年9月至2014年6月攻读中国药科大学药物化学博士学位。2014年7月毕业并获理学博士学位，

1. 国家自然科学基金面上项目，31870325，基于微管蛋白抑制的抗乳腺癌多药耐药天然呋喃[2,3-b]喹啉类化合物的发现与结构修饰研究，2019/01-2022/12，在研，主持。

2. 国家自然科学基金青年基金项目，31500277，基于拓扑异构酶II抑制的白鲜皮中抗肺癌喹诺酮的结构修饰与构效关系研究，2016/01-2018/12，在研，主持。

3. 中央高校基本业务经费重点项目，ZY20180117041，基于天然呋喃喹啉类化合物设计合成兼具抗菌及抗肿瘤活性的新型Topo II抑制剂，2018/7-2020/6，在研，主持。

4. 横向课题，校合2018-中12，保健食品生物利用度、产品功能及毒理学研究，2018/06-2021/05，在研，主持。

5. 横向课题，校合2017-中56，陕西安康普欣药业联合建设中药配方颗粒标准化工程中心，2018/03-2020/02，在研，主持。

6. 横向课题，山东罗欣药业盐酸美金刚原料结构测试试验（校合2018-中4）、盐酸头孢他美酯原料结构确证（校合2017-中14）及原料结构测试试验（校合2017-中52，校合2019-中015），2017/01-2019/12，在研，主持。

7. 广西艾滋病防治研究重点实验室开放课题基金，gklapt201701，基于HIV整合酶抑制的天然抗艾滋病病毒4-喹啉酮类药物的筛选与结构修饰研究，2018/01-2020/12，在研，主持。

8. 区域性高发肿瘤早期防治研究重点实验室开放课题基金，GK2015-TKF02，白鲜皮中抗肝癌呋喃喹诺酮的发现与构效关系研究，2016/1-2017/12，结题，主持。

9. 陕西省肿瘤精准医学重点实验室开放课题，KLTPM-SX2022-B3，兼具抗菌和肿瘤活性的天然呋喃喹啉类DNA拓扑异构酶II抑制剂的筛选与结构修饰研究，2018/1-2020/12，在研，主持。

10. 科技部“重大新药创制”重大科技专项课题、2011ZX09307-002、中药化学与活性成分库的子课题中药化学成分库建设、参加。

1.Sun Jianbo,Qu Wei, Wang Pei, Wu Feihua*, Wang Liying, Liang Jingyu*. Degraded limonoids and quinoline alkaloids from Dictamnus angustifoliusG. Don ex Sweet. and their anti-platelet aggregation activity. Fitoterapia, 2013, 90:209-213.

2.Sun Jianbo#*,Jiang Neng#, Lv Mengying, Tang Benqin, Wang Pei, Liang Jingyu, Chen Li*.Anstifolines A and B, two dimeric furoquinoline alkaloids from the root bark of Dictamnus angustifolius. RSC Advances, 2016, 47(28):22550-22554.

3.Sun Jianbo, Wang Xinzhi, Wang Pei, Li Linzhen, Qu Wei*, Liang Jingyu*. Antimicrobial, antioxidant and cytotoxic properties of essential oil from Dictamnus angustifolius. Journal of Ethnopharmacology, 2015, 159:296-300.

4.Wang Bing, Li Qiangqiang, Shi Wei, Chen Li*, Sun Jianbo*. Design, synthesis, and cytotoxic evaluation of novel furo[2,3-b]quinoline derivatives. Chemical Biology & Drug Design. 2018, 91(4):957-961.

5.Sun Jianbo#, Jiang Neng#, Lv Mengying, Wang Pei, Xu Fengguo, Liang Jingyu*, Qu Wei*. Limonoids from the root bark of Dictamnus angustifolius: potent neuroprotective agent with biometal chelation, halting copper redox cycling properties. RSC Advances, 2015, 5:24750-24757.

6.Sun Jianbo#, Tang Benqin#, Li Qiangqiang, Wang Bing, Liang Jingyu*, Chen Li*.Cytotoxic limonoids from the root bark of Dictamnus angustifolius. Fitoterapia, 2016, 115:92-95.

7.Lv Mengying, Tian Yuan, Zhang Zunjian, Xu Fengguo*, Sun Jianbo*. Plant metabolomics driven chemical and biological comparison of the root bark of Dictamnus dasycarpus and Dictamnus angustifolius. 2015, RSC Advances, 5(20):15700-15708.

8.Lv Mengying, Xu Ping, Tian Yuan, Liang Jingyu, Gao Yiqiao, Xu Fengguo, Zhang Zunjian*, Sun Jianbo*. Medicinal uses, phytochemistry and pharmacology of the genus Dictamnus (Rutaceae). Journal of Ethnopharmacology, 2015, 171: 247-263.

9.Li Qixing, Zou Pian, Sun Jianbo*, Chen Li*. O2-(2,4-dinitrophenyl) diazeniumdiolates derivatives: Design, synthesis, cytotoxic evaluation and reversing MDR in HepG-2/ADR cells. European Journal of Medicinal Chemistry, 2018, 143:732-744.

10.Bao Na#, Ou Jinfeng#, Xu Manyi, Guan Fuqin, Shi Wei, Sun Jianbo*, Chen Li*. Novel NO-releasing plumbagin derivatives: Design, synthesis and evaluation of antiproliferative activity. European Journal of Medicinal Chemistry, 2017, 137:88-95.

11.Bao Na#, Ou Jinfeng#, Li Na, Zou Pian, Sun Jianbo*, Chen Li*. Novel anticancer hybrids from diazen-1-ium-1,2-diolate nitric oxide donor and ROS inducer plumbagin: Design, synthesis and biological evaluations. European Journal of Medicinal Chemistry, 2018, 154:1-8.

12.Shi Wei, Hu Jinglin, Bao Na, Li Dongang, Chen Li*, Sun Jianbo*. Design, synthesis and cytotoxic activities of scopoletin-isoxazole and scopoletin-pyrazole hybrids. Bioorganic and Medicinal Chemistry Letters, 2017, 27(2):147-151.

13.Shi Wei, Zhang Jinlu, Bao Na, Guan Fuqin, Chen Li*, Sun Jianbo*.Design, synthesis and cytotoxic evaluation of novel scopoletin derivatives. Chemical Biology & Drug Design. 2018, 91(2):641-646.

14.Liu Yan, Wang Tingting, Ling Yong, Bao Na, Shi Wei, Chen Li*, Sun Jianbo*. Design, synthesis and cytotoxic evaluation of nitric oxide-releasing derivatives of isosteviol. Chemical Biology & Drug Design. 2017, 90(3):473-477.

15.Liu Jinhong, Zhu Zifei, Tang Jia, Lin Qinghua, Chen Li*, Sun Jianbo*. Design and Synthesis of NO-releasing Betulinic Acid Derivatives as Potential Anticancer Agents. Anti-cancer Agents in Medicinal Chemistry, 2017, 17:241-249.

16.Wang Pei#, Sun Jianbo#, Gao Enze, Zhao Yunli, Qu Wei, Yu Zhiguo*. Simultaneous determination of limonin, dictamnine, obacunone and fraxinellone in rat plasma by a validated UHPLC-MS/MS and its application to a pharmacokinetic study after oral administration of Cortex Dictamni extract. Journal of Chromatography B, 2013, 928(0):44-51.

17.Wang Pei#, Sun Jianbo#, Xu Jingyao, Gao Enze, Yan Qin, Qu Wei, Zhao Yunli, Yu Zhiguo*. Pharmacokinetics, tissue distribution and excretion study of dictamnine, a major bioactive component from the root bark of Dictamnus dasycarpus Turcz. (Rutaceae). Journal of Chromatography B, 2013, 942-943:1-8.

申请发明专利3项